Literature DB >> 33317678

Systematic rifampicin resistance errors with Xpert® MTB/RIF Ultra: implications for regulation of genotypic assays.

S V Omar1, D Hillemann2, S Pandey3, M Merker4, A-K Witt2, D Nadarajan2, I Barilar5, A Bainomugisa3, E C Kelly6, R Diel7, D S Vidanagama8, A I P Samarasinghe9, M R Cader9, U Götsch10, E Lavu11, A Alabi12, T Schön13, C Coulter3, S Niemann4, F P Maurer14, N A Ismail15, C U Köser6, F Ismail16.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2020        PMID： 33317678     DOI： 10.5588/ijtld.20.0396

Source DB:  PubMed          Journal:  Int J Tuberc Lung Dis        ISSN： 1027-3719            Impact factor:   2.373


× No keyword cloud information.
  3 in total

1.  On the Consequences of Poorly Defined Breakpoints for Rifampin Susceptibility Testing of Mycobacterium tuberculosis Complex.

Authors:  Claudio U Köser; Sophia B Georghiou; Thomas Schön; Max Salfinger
Journal:  J Clin Microbiol       Date:  2021-03-19       Impact factor: 5.948

2.  Targeted next-generation sequencing: a Swiss army knife for mycobacterial diagnostics?

Authors:  Sagal Mohamed; Claudio U Köser; Max Salfinger; Wladimir Sougakoff; Scott K Heysell
Journal:  Eur Respir J       Date:  2021-03-18       Impact factor: 16.671

3.  False detection of rifampicin resistance using Xpert® MTB/RIF Ultra assay due to an A451V mutation in Mycobacterium tuberculosis.

Authors:  Margaret M Fitzgibbon; Emma Roycroft; Gerard Sheehan; Anne-Marie Mc Laughlin; Keith Ian Quintyne; Elaine Brabazon; Mary O'Meara; Peter R Flanagan; A-Louise Seagar; Ian F Laurenson; Joseph Keane; Thomas R Rogers
Journal:  JAC Antimicrob Resist       Date:  2021-08-11
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.